Clinical Trial: Glucocorticoids in Patients With IgG4-RD

Study Status: Recruiting
Recruit Status: Unknown status
Study Type: Interventional




Official Title: A Randomized Trial of Glucocorticoids in Patients With IgG4-Related Disease

Brief Summary: This is a randomized, open-label, single-center clinical trial to compare the efficacy and safety profile for medium-dose versus high dose glucocorticoid in patients with IgG4-related Disease. Patients will be followed for three months to measure the primary outcome and secondary outcomes.